Cardiovascular safety - PowerPoint PPT Presentation

Oral Hypoglycemic Agents in T2DM

Oral Hypoglycemic Agents in T2DM. MALBOOSBAF, Ramin. MD. 17 JAN 2018. Overview of the pathogenesis of T2DM. Insulin secretory dysfunction Insulin resistance (muscle, fat, liver) Increased endogenous glucose production Decreased incretin effect Reduced renal glucose excretion

★ ★ ★ ★ ★

653 views • 56 slides

Regulatory History

Regulatory History. JOINT MEETING OF THE ARTHRITIS AND THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE Jonca Bull, M.D. Office of New Drugs February 16, 2005. Overview of NSAID Class.

★ ★ ★ ★ ★

388 views • 12 slides

FDA Hearing : Cardiovascular Safety of ADHD Medications in Children &amp; Adolescents

FDA Hearing : Cardiovascular Safety of ADHD Medications in Children &amp; Adolescents. M. Christopher Griffith, M.D. Clinical Assistant Professor: Emory University School of Medicine Morehouse School of Medicine. Introduction.

★ ★ ★ ★ ★

190 views • 11 slides

View Cardiovascular safety PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Cardiovascular safety PowerPoint presentations. You can view or download Cardiovascular safety presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.

Cardiovascular safety - PowerPoint PPT Presentation

Oral Hypoglycemic Agents in T2DM

Regulatory History

FDA Hearing : Cardiovascular Safety of ADHD Medications in Children &amp;amp; Adolescents

FDA Hearing : Cardiovascular Safety of ADHD Medications in Children & Adolescents